Sagimet Biosciences Statistics Share Statistics Sagimet Biosciences has 31M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 31M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 42.79% Shares Floating 26.13M Failed to Deliver (FTD) Shares 13,311 FTD / Avg. Volume 1.02%
Short Selling Information The latest short interest is 2.8M, so 8.61% of the outstanding
shares have been sold short.
Short Interest 2.8M Short % of Shares Out 8.61% Short % of Float 9.74% Short Ratio (days to cover) 4.28
Valuation Ratios The PE ratio is -3.1 and the forward
PE ratio is -3.71.
Sagimet Biosciences's PEG ratio is
0.59.
PE Ratio -3.1 Forward PE -3.71 PS Ratio 0 Forward PS 2247.6 PB Ratio 0.91 P/FCF Ratio -3.32 PEG Ratio 0.59
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Sagimet Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 34.3,
with a Debt / Equity ratio of 0.
Current Ratio 34.3 Quick Ratio 34.3 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.25M Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 171.54% in the
last 52 weeks. The beta is 3.38, so Sagimet Biosciences's
price volatility has been higher than the market average.
Beta 3.38 52-Week Price Change 171.54% 50-Day Moving Average 8.58 200-Day Moving Average 5.34 Relative Strength Index (RSI) 41.01 Average Volume (20 Days) 1,306,404
Income Statement
Revenue n/a Gross Profit n/a Operating Income -54.45M Net Income -45.57M EBITDA -45.57M EBIT -45.57M Earnings Per Share (EPS) -1.45
Full Income Statement Balance Sheet The company has 75.84M in cash and 78K in
debt, giving a net cash position of 75.76M.
Cash & Cash Equivalents 75.84M Total Debt 78K Net Cash 75.76M Retained Earnings -295.31M Total Assets 137.41M Working Capital 119.95M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -42.44M
and capital expenditures 0, giving a free cash flow of -42.44M.
Operating Cash Flow -42.44M Capital Expenditures n/a Free Cash Flow -42.44M FCF Per Share -1.35
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
